Botox VS Dysport
August 26, 2019 - Rhys Branman, MD
Like BOTOX®, Dysport® is a neuromuscular wrinkle blocker; it blocks the nerve impulses to tiny muscles that cause wrinkles in the face, allowing them to flatten out and become less visible. BOTOX® and Dysport® are both botulinum toxin type A… When Do I Start Botox?
January 16, 2020 - Rhys Branman, MD
There has been a trend in the past couple of years for young women to seek BOTOX® as a preventative measure against aging and wrinkles. If you ask doctors, they will vary in their opinions not only about the wisdom … Over 50 Make Over?
July 26, 2018 - Rhys Branman, MD
Let’s not talk about the shows “Extreme Makeovers” or “I Want a Famous Face.” These are completely unrealistic goals for most women, certainly financially, if not medically. Do realize that the person made over for those shows are hand-picked to… Celebrity Gossip?
January 6, 2016 - Rhys Branman, MD
When it comes to celebrities and the tabloids, all we hear about is cosmetic surgery gone wrong. But what about all those subtle, successful cosmetic surgeries the stars have had? The camera picks up every flaw and shadow. Movies stars… Bro-tox?
November 7, 2023 - Rhys Branman, MDStudy Finds Dysport Gives Patients Quick Results
December 2, 2013 - Rhys Branman, MDBotox Gets U.K. License as Migraine Treatment
January 15, 2020 - Rhys Branman, MDNew Research About Botox and Migraines
October 16, 2020 - Rhys Branman, MD
New research published in Archives of Dermatology supports the conclusion that BOTOX® can be used to treat migraine headaches. According to authors of the study, BOTOX® injections “at doses appropriate for cosmetic purposes may be sufficient to prevent migraine attacks.”… Botox and Dysport Both Doing Well in Competitive Market
May 18, 2017 - Rhys Branman, MD
Allergan and Medicis are showing increased profits this quarter, and analysts are partially attributing the growth to third quarter BOTOX® and Dysport® sales.
According to CNN Money , revenues for Dysport® manufacturer Medicis last quarter are 30 percent above last… 